How the Trust is performing
The Trust collects data each month to monitor how we are performing in key areas. See below for our most recently available figures. Further information can be found in the monthly Trust board performance report.
|National standardMa||Jan 2021||Feb 2021||March 2021||April 2021||May 2021||June 2021|
|A&E: Trust overall||70.2%||89.5%||92.9%||90.0%||88.2%||88.3%|
|Cancer two-week wait||87.8%||90.7%||89.0%||87.3%||88.6%|
|Cancer 62-day wait||80.1%||73.3%||78.5%||72.3%||74.5%|
|Cases of MRSA||2||1||0||0||0||0|
|Cases of C difficile||6||2||3||2||4||2|
The standards explained
A&E four-hour wait The national standard is that 95 per cent of all patients attending A&E should be treated, admitted or discharged within four hours.
18-week referral to treatment 92% of patients waiting to start elective treatment should have waited less than 18 weeks.
Cancer two-week wait 93% of urgent cancer outpatient referrals should be seen within 14 days.
Cancer 62-day standard 85% of patients should begin treatment within 62 days of being referred by their GP.
MRSA The Trust should have no cases of this hospital acquired infection.
C. difficile Cases of this hospital acquired infection should not exceed 27 cases per year.